Medigene AG Expands Patent Portfolio for its End-to-End Platform
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
News
Medigene AG Expands Patent Portfolio for its End-to-End Platform
Planegg/Martinsried, May 22, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company…
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Keros Therapeutics Presents Preclinical and Clinical Data from its KER-012 Program at the American Thoracic Society International Conference
LEXINGTON, Mass., May 22, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a…
Tilray Brands Chairman and CEO Irwin D. Simon to Participate in the Bernstein 39th Annual Strategic Decisions Conference
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX:…
Tilray Brands Chairman and CEO Irwin D. Simon to Participate in the Bernstein 39th Annual Strategic Decisions Conference
NEW YORK, May 22, 2023 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX:…
Quanta Therapeutics Raises Over $50 Million in Series D Financing to Advance its Pipeline of KRAS Inhibitors
– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024…
Quanta Therapeutics Raises Over $50 Million in Series D Financing to Advance its Pipeline of KRAS Inhibitors
– Funds will support advancement of two KRAS inhibitor programs into the clinic in 2024…
Lumos Pharma to Participate in World Orphan Drug Congress USA
AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…
Lumos Pharma to Participate in World Orphan Drug Congress USA
AUSTIN, Texas, May 22, 2023 (GLOBE NEWSWIRE) — Lumos Pharma, Inc. (NASDAQ:LUMO), a biopharmaceutical company…
Scilex Holding Company Added to the Preliminary List of the Russell 3000® Index and the Small-Cap Russell 2000® Index as part of the 2023 Russell Indexes Annual Reconstitution in June 2023
PALO ALTO, Calif., May 22, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
Scilex Holding Company Added to the Preliminary List of the Russell 3000® Index and the Small-Cap Russell 2000® Index as part of the 2023 Russell Indexes Annual Reconstitution in June 2023
PALO ALTO, Calif., May 22, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”),…
FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients
XBiotech Believes its Drug Candidate Natrunix Could Revolutionize Arthritis Treatment AUSTIN, Texas, May 22, 2023…
FDA Authorizes Phase II Study for Natrunix in Rheumatoid Arthritis Patients
XBiotech Believes its Drug Candidate Natrunix Could Revolutionize Arthritis Treatment AUSTIN, Texas, May 22, 2023…
Lucy Scientific Discovery Inc.’s Functional Amanita Line Now Available for Purchase through Retail Channels
VANCOUVER, British Columbia, May 22, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (NASDAQ: LSDI),…
Lucy Scientific Discovery Inc.’s Functional Amanita Line Now Available for Purchase through Retail Channels
VANCOUVER, British Columbia, May 22, 2023 (GLOBE NEWSWIRE) — Lucy Scientific Discovery Inc. (NASDAQ: LSDI),…
Vistin Pharma ASA: Minutes from the Annual General Meeting 2023
Oslo, Norway, 22 May 2023 Vistin Pharma ASA (OSE: VISTIN): Please find attached the minutes…
Vistin Pharma ASA: Minutes from the Annual General Meeting 2023
Oslo, Norway, 22 May 2023 Vistin Pharma ASA (OSE: VISTIN): Please find attached the minutes…
GRI Bio (NASDAQ: GRI) Provides Business Outlook and Highlights Upcoming Milestones for Innovative Pipeline of NKT Cell Modulators
Rapidly advancing clinical pipeline in potential high-value inflammatory, fibrotic and autoimmune diseases Leading NKT regulation…
GRI Bio (NASDAQ: GRI) Provides Business Outlook and Highlights Upcoming Milestones for Innovative Pipeline of NKT Cell Modulators
Rapidly advancing clinical pipeline in potential high-value inflammatory, fibrotic and autoimmune diseases Leading NKT regulation…